​

Krystal Biotech Ownership | Who Owns Krystal Biotech?

OverviewForecastRevenueFinancialsChartTranscripts

Krystal Biotech Ownership Summary

Krystal Biotech is owned by 55.61% institutional investors, 11.73% insiders, and 32.66% retail investors. Fmr is the largest institutional shareholder, holding 15.02% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.41% of its assets in Krystal Biotech shares.

KRYS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKrystal Biotech55.61%11.73%32.66%
SectorHealthcare Stocks 232.51%10.72%-143.22%
IndustryBiotech Stocks 384.55%10.58%-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.34M15.02%$766.40M
Blackrock3.95M13.95%$724.98M
Blackrock funding, inc. /de3.94M13.60%$970.83M
Avoro capital advisors2.78M9.61%$490.36M
Vanguard group2.78M9.60%$685.10M
State street1.40M4.83%$246.43M
Soleus capital management941.06K3.25%$232.01M
Capital world investors809.50K2.80%$199.57M
Frazier life sciences management688.46K2.38%$121.53M
Redmile group661.39K2.29%$116.75M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Redmile group661.39K11.36%$116.75M
S squared96.22K9.19%$23.72M
Soleus capital management941.06K8.56%$232.01M
Avoro capital advisors2.78M6.34%$490.36M
Evolutionary tree capital management16.81K4.81%$4.14M
Palisades investment partners42.77K3.98%$10.54M
Frazier life sciences management688.46K3.64%$121.53M
Braidwell lp520.40K2.73%$91.87M
Healthinvest partners ab33.85K2.66%$8.35M
Acuta capital partners10.57K1.93%$1.87M

Top Buyers

HolderShares% AssetsChange
Blackrock3.95M0.02%2.14M
Norges bank284.57K0.01%284.57K
William blair investment management376.34K0.26%227.04K
Price t rowe associates inc /md/467.06K0.01%205.68K
Avoro capital advisors2.78M6.34%117.78K

Top Sellers

HolderShares% AssetsChange
Braidwell lp520.40K2.73%-207.41K
T. rowe price investment management---185.55K
Baker bros. advisors lp---169.93K
Ubs asset management americas33.62K0.00%-168.97K
Lord, abbett---151.22K

New Positions

HolderShares% AssetsChangeValue
Norges bank284.57K0.01%284.57K$70.16M
Eagle asset management76.26K0.07%76.26K$13.90M
Perceptive advisors35.00K0.18%35.00K$6.18M
Granite investment partners25.76K0.38%25.76K$6.35M
Eam investors24.67K0.68%24.67K$6.08M

Sold Out

HolderChange
Tortoise investment management-1.00
Tradewinds capital management-1.00
Tfc financial management-1.00
Assetmark-1.00
Mendota financial group-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025232-22.15%16,100,358-42.52%550.59%128-16.88%74-12.94%
Sep 30, 20252894.33%27,787,3363.78%961.12%1497.19%83-10.75%
Jun 30, 2025280-10.26%27,626,5581.12%951.06%140-8.50%94-16.07%
Mar 31, 20253109.54%27,310,084-1.64%941.01%15213.43%11112.12%
Dec 31, 2024175-41.28%17,639,222-37.00%610.65%85-45.51%63-31.52%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology1.86M6.41%-
iShares Core S&P Small-Cap ETF1.51M5.23%-
Fidelity Growth Compy Commingled Pl S964.96K3.33%1.30K
Fidelity Growth Compy Commingled Pl O915.43K3.19%-
American Funds SMALLCAP World A886.71K3.07%-
Vanguard US Total Market Shares ETF824.72K2.86%704.00
Vanguard Total Stock Mkt Idx Inv818.09K2.83%-17.16K
Fidelity Growth Company Fund702.99K2.43%-4.21K
Vanguard Small Cap Index631.98K2.18%-3.60K
iShares Russell 2000 ETF596.22K2.06%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 09, 2026ROMANO KATHRYN Chief Accounting OfficerSell$769.56K
Feb 09, 2026ROMANO KATHRYN Chief Accounting OfficerSell$254.00K
Feb 09, 2026ROMANO KATHRYN Chief Accounting OfficerSell$541.12K
Feb 09, 2026ROMANO KATHRYN Chief Accounting OfficerSell$1.55M
Feb 09, 2026ROMANO KATHRYN Chief Accounting OfficerSell$151.60K

Insider Transactions Trends

DateBuySell
2026 Q1-7
2025 Q4-32
2025 Q3-30
2025 Q2--
2025 Q1-21

KRYS Ownership FAQ

Who Owns Krystal Biotech?

Krystal Biotech shareholders are primarily institutional investors at 55.61%, followed by 11.73% insiders and 32.66% retail investors. The average institutional ownership in Krystal Biotech's industry, Biotech Stocks , is 384.55%, which Krystal Biotech falls below.

Who owns the most shares of Krystal Biotech?

Krystal Biotech’s largest shareholders are Fmr (4.34M shares, 15.02%), Blackrock (3.95M shares, 13.95%), and Blackrock funding, inc. /de (3.94M shares, 13.60%). Together, they hold 42.57% of Krystal Biotech’s total shares outstanding.

Does Blackrock own Krystal Biotech?

Yes, BlackRock owns 13.95% of Krystal Biotech, totaling 3.95M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 724.98M$. In the last quarter, BlackRock increased its holdings by 2.14M shares, a 118.67% change.

Who is Krystal Biotech’s biggest shareholder by percentage of total assets invested?

Redmile group is Krystal Biotech’s biggest shareholder by percentage of total assets invested, with 11.36% of its assets in 661.39K Krystal Biotech shares, valued at 116.75M$.

Who is the top mutual fund holder of Krystal Biotech shares?

Fidelity Select Biotechnology is the top mutual fund holder of Krystal Biotech shares, with 6.41% of its total shares outstanding invested in 1.86M Krystal Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools